CVS Health Corp. said Wednesday it will expand access to opioid overdose-reversal drug naloxone to seven additional states, starting later this month, bringing the total number of states where it is accessible in CVS pharmacies to 30 states. The expansion will start with New Mexico, the followed by Louisiana in June; Florida, Colorado, Idaho and Oregon in July; and Washington in August. "Expanding access to the overdose-reversal drug naloxone is a critical part of our national strategy to stop the prescription drug and heroin overdose epidemic--along with effective prevention, treatment, and enforcement," said Michael Botticelli, director of National Drug Control Policy. The stock, which was up 0.6% in light premarket trade, has lost 0.4% year to date through Tuesday, while the S&P 500 has gained 1.6%.
Copyright © 2016 MarketWatch, Inc.
Continue Reading Below